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ABSTRACT
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•

Alexandru Movila, Ph.D. (Committee Member)

•

Alireza Heidari, Ph.D. (Committee Member)

BACKGROUND: Early childhood caries (ECC) is one of the most prevalent infectious
diseases in childhood worldwide. It afflicts 23% of the preschoolers in the U.S. It most
frequently targets children from poor socioeconomic families and racial/ethnic minority
backgrounds and becomes a serious public health problem. The major pathogen of ECC is
Streptococcus mutans (S. mutans). However, the occurrence of ECC is positively
associated with the presence of Candida albicans (C. albicans).
It is well established that Silver Diamine Fluoride (SDF), a recent Food and Drug
Administration (FDA)-off labeled approved agent for arresting dental caries, exhibits a
robust antibacterial effect on S. mutans associated with ECC. Very interestingly, C.
albicans has been implicated as one of the major contributing factors for the high
vi

prevalence of ECC, indicating that the reduction of C. albicans colonization in the oral
cavity may suppress ECC. However, it remains elusive if SDF can also mediate an
antifungal effect on C. albicans.
OBJECTIVE: The purpose of this study was to evaluate the effect of SDF on the growth of
C. albicans and compare it to that of fluoride varnish and fluconazole, and to determine
the minimum inhibitory concentration (MIC) of SDF on the growth of C. albicans.
HYPOTHESIS: We hypothesized that:
There are significant differences in the inhibitory effect on the growth of C. albicans among
SDF, fluoride varnish, fluconazole (positive control), and Phosphate Buffered Saline (PBS:
negative control) groups.
Null hypothesis: There are no significant differences in the inhibitory effect on the growth
of C. albicans among SDF, fluoride varnish, fluconazole (positive control), and Phosphate
Buffered Saline (PBS: negative control) groups, or SDF doesn’t possess any inhibitory
effect of the growth of C. albicans.
MATERIALS AND METHODS: The antifungal effect of the tested groups was determined
using both disk diffusion assay and minimum inhibitory concentration (MIC) assay. In the
disc diffusion assay, SDF (38%), fluoride varnish (5%), fluconazole (25 µg/mL, positive
control) and PBS (negative control) were applied to a paper disc placed on the MuellerHinton agar plate on which low concentration (invisible level) of C. albicans was evenly
spread (1×105/plate or 1×106/plate). After incubation at 37°C in aerobic condition for 24
hours, the diameter of the inhibition zone around each disc was measured with a digital
caliper.
vii

In MIC assay, the minimum inhibitory concentration of SDF (38%) and fluconazole (25
µg/mL, positive control group) were tested by the exposure of C. albicans of 1 × 105
concentration in a 96-well plate to the serial dilutions of the respective reagent. After
incubation at 37°C in aerobic condition for 24 hours, the relative amount of C. albicans
grown in the 96-well plate was measured using a plate reader and the minimum
concentration of reagent that inhibited the growth of C. albicans was determined.
In the disc diffusion assay, the experiment was performed in quadruplicates and repeated
three times. A general linear model (ANOVA) followed by Tukey’s HSD test was
employed for statistical analysis. In MIC assay, the minimum inhibitory concentration
percentage of each material’s original concentration was calculated.
RESULTS: SDF (38%) demonstrated a significantly higher inhibitory effect (P < .001)
against C. albicans growth compared to fluconazole. However, both fluoride varnish and
PBS showed no inhibitory effect on the growth of C. albicans.
MIC of SDF was 0.009% of its original concentration, compared to 0.6% of that for
fluconazole, suggesting that SDF has antifungal effect even at lower concentration than
antifungal effect mediated by fluconazole.
CONCLUSION: This study, for the first time, demonstrated the inhibitory effect of SDF on
the growth of C. albicans, indicating that SDF possesses antifungal property, which would
be translated into the novel approach in arresting ECC associated with C. albicans.
This study allows a better understanding of the SDF effect in arresting ECC and discovers
a new beneficial mechanism of SDF, in addition to its known mechanisms.
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CHAPTER 1: INTRODUCTION
1.1

BACKGROUND

1.1.1 Early Childhood Caries (ECC)
According to the American Academy of Pediatric Dentistry (AAPD), ECC is defined as
the presence of one or more decayed (noncavitated or cavitated lesions), missing (due to
caries), or filled tooth surfaces in any primary tooth in a child under the age of six, whereas
severe early childhood caries (S-ECC) is defined as any sign of smooth-surface caries in a
child younger than three years aged, and from ages three through five, one or more
cavitated, missing (due to caries), or filled smooth surfaces in primary maxillary anterior
teeth or a decayed, missing, or filled score of greater than or equivalent to four (age 3),
greater than or equivalent to five (age 4), or greater than or equivalent to six (age 5) (1).
Several terminologies were used to describe the condition and its relation to the
inappropriate feeding practices such as nursing bottle caries, nursing caries, rampant caries,
baby bottle caries, baby bottle tooth decay, milk bottle syndrome, and prolonged nursing
habit caries (2).
The child with ECC is often at higher risk of new carious lesions in both the primary and
permanent dentition and may suffer from considerable pain, infections, and abscesses (3,
4). If the damage extent leads to the extraction of the anterior teeth by age 2 or 3 years, the
child may suffer further of developmental delays involving speech articulation (5).
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The pain and discomfort of ECC may lead to difficulty in eating, malnutrition, delay in
physical development, gastrointestinal disorders, difficulty in sleeping, emergency room
visits, loss of school days, diminished ability to learn, and diminished oral health-related
quality of life (4, 6-9). It usually needs high treatment costs, hospitalizations and thus
constitute a major challenge in public health (6).
1.1.1.1 Clinical Presentation and Classification
ECC has a singular characteristic in clinical appearance which is a rapid development of
caries that affects the teeth soon after they emerge in the oral cavity (10).
These lesions involve tooth surfaces that are usually less prone to caries development, such
as the labial surfaces of maxillary incisors and lingual and buccal surfaces of maxillary and
mandibular molars. ECC initially presents as dull white or brown spots on maxillary
incisors along the gingival margin, which progresses to an entire destruction of the crown,
reaching to root stumps (11). Several researchers have developed classification systems for
early childhood caries (Tables 1.1–1.3).
Table 1.1: Classification based on the pattern of ECC presentation (10).
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Table 1.2: Classification based on the pattern of ECC presentation (10).

Table 1.3: Classification of ECC and Severe Early Childhood Caries (S-ECC) (11, 12).
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1.1.1.2 Epidemiology
Despite the decline in the prevalence of dental caries in children, caries in preschool
children remains a major problem in both developed and developing countries (13). The
prevalence of ECC varies widely with several factors like race, culture, ethnicity,
socioeconomic status, lifestyle, dietary pattern, fluoride exposure, and oral hygiene
practices. In most developed countries, the prevalence rate of ECC is between 1 and 12%
(14). Prevalence has been reported to be as high as 70% among children with low
socioeconomic status in less developed countries as well as disadvantaged groups in the
developed countries (15, 16).
The national surveys from some countries, such as Sweden (11.4%), Italy (7–19.0%),
Greece (36%), Brazil (45.8%), India (51.9%), and China (85.5%), showed the inconsistent
prevalence of ECC (17-20).
In the U.S., epidemiologic data from a 2011-2012 national survey clearly indicate that ECC
remains highly prevalent in poor and near poor U.S. preschool children. For the general
population of preschool children, the prevalence of ECC, as measured by decayed and
filled tooth surfaces (dfs), is unchanged from previous surveys, but the filled component
(fs) has greatly increased indicating that more treatment is being provided (21).
According to a study, the highest prevalence of ECC in children aged between 8 months
and 7 years is found in the 3- to 4-year-old age group and that boys are significantly more
affected than girls (22).
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1.1.1.3 Etiology of ECC
Dental caries results from the interaction of cariogenic microorganisms, fermentable
carbohydrates (substrate), and susceptible tooth surface/host that present concurrently to
initiate and progress the disease. Other risk factors associated with ECC have also
documented including low socioeconomic status, minority status, low birth weight, mother
oral health status, child oral health-care behavior; late commencement of child tooth
brushing and irregular brushing habits, feeding behavior; night time bottle feeding and
frequent consumption of cariogenic food, (Figure 1.1) (23-25).

Figure 1.1: The influence of host–microbe–diet interactions in the etiology and
pathogenesis of early childhood caries (76).
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1.1.1.3.1 Cariogenic Microorganisms
•

Bacteria:

The most common microorganisms associated with the initiation of ECC are Streptococcus
mutans (S. mutans) and Streptococcus sobrinus. Lactobacilli also play an important role in
the development and progression of caries lesions, but not its initiation (26). S. mutans
converts fermentable carbohydrates into acids, which contribute to the demineralization of
tooth structure (27, 28). Preschool children with high levels of S. mutans in the oral cavity
had a greater risk for new lesions development and higher caries prevalence (29). It has
been found that children having high S. mutans levels were five times more prone to have
dental caries (30). S. mutans isolates from infants indicated that these bacteria can be
transmitted from mother to child via vertical transmission through saliva which is
considered as the major source of acquiring the S. mutans during the first 12–24 months
(30-32). Frequent maternal snacking and sugar exposure with poor oral hygiene
maintenance and sharing food with their children increase the chances of transmission of
the infection to the child (33). Also, S. mutans can be horizontally transmission between
siblings (34, 35). The infants delivered by C-section acquire S. mutans earlier than
vaginally delivered infants since these deliveries are more aseptic and the atypical
microbial environment increases the chances of S. mutans colonization (36). Other bacteria
like Actinomyces species, specifically Actinomyces gerencseriae, were also related to
caries initiation (37), while Bifidobacterium species were related to deep caries lesions
(37). Few non-mutans streptococci that have acidogenic and aciduric properties were also
associated with caries (38, 39).
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Saliva has a protective feature against dental caries by providing the antimicrobial
properties, the buffering capacity, and clearance of foods from the mouth that are important
in reducing the development of caries (40). The low salivary flow rate at night may increase
the caries risk for infants and toddlers with bedtime bottle feeding (41).
•

Fungi:

Epidemiological data suggest that C. albicans also plays a significant role in the
pathogenesis of dental caries. Several clinical studies have shown that C. albicans is
frequently detected in high numbers in plaque-biofilms from children and toddlers with
ECC (42-48). A systematic review of the literature published in 2018 revealed that children
with oral C. albicans had larger than 5 times higher odds of having ECC compared to those
without C. albicans and the prevalence of C. albicans in children with ECC was
significantly higher than in children without caries (49). A similar outcome was reported
in another study in which the frequency of C. albicans isolated in dental plaque from
children with ECC was confirmed to be higher than that in caries-free children (44.1 vs.
19.2 %, χ2 = 22.213, p < 0.001), which indicated that C. albicans is significantly associated
with ECC (50).
C. albicans may be transmitted vertically from caregiver to child through salivary contact
suggesting that the mother might be a source for C. albicans acquisition in the oral cavity
of children affected by ECC (51). Recent evidence supports that the interactions between
C. albicans and S. mutans are associated with the pathogenesis of ECC. It has been reported
that the presence of C. albicans enhances S. mutans growth, and accumulation within
bioﬁlms in vitro (52-54). For the coinfected animal, moderate to severe carious lesions
7

exposing dentin were observed supporting the synergistic effect of C. albicans and S.
mutans in amplifying dental caries, (Figure 1.2) (54).
In vivo, a study using a rodent model and a diet rich in sucrose showed that a high level of
S. mutans in plaque-bioﬁlms associated with C. albicans co-infection leads to onset of
rampant caries similar to ECC (55).

Figure 1.2: Images of teeth from rats infected with S. mutans UA159 and/or C.
albicans SC5314, or left uninfected, after 2 weeks. Black arrows indicate moderate to
severe carious lesions, red arrows indicate the most severe carious lesions (54).
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Furthermore, C. albicans appears to activate S. mutans genes associated with bioﬁlm
formation and genetic competence (56). It has been reported that C. albicans can change
the gene expression in S. mutans leading to differentially expression of 393 genes that
increase the carbohydrate utilization and metabolism by S. mutans resulting in a significant
amount of format in the culture medium of co-cultured bioﬁlms and influences the genes
transcription of S. mutans that are associated with its virulence and ﬁtness (57). Regarding
C. albicans’s potential to induce dental caries, researchers have found that the
acidogenicity and aciduricity are important factors in C. albicans virulence for ECC
development (48, 58). More importantly, an in vivo study demonstrated the pronounced
ability of C. albicans to produce acids causing advanced occlusal caries in rats (59).
1.1.1.3.2 Diet
Diet contents and dietary practices play a significant role in the development of ECC. High
consumption of fermentable carbohydrates is a strong risk factor associated with microbial
etiology of dental caries (59, 60). Also, the inappropriate dietary practice can prolong the
exposure of the teeth to fermentable carbohydrates that aggravates the ECC. It has been
found that the frequent nighttime bottle-feeding with milk and ad libitum breastfeeding has
been associated with ECC in children (61). The breastfeeding duration was also found to
be associated with an increased risk for ECC among 2- to 5-year-old children (62). A result
of a systematic review revealed that breastfeeding for more than a year and at night is
associated with an increased prevalence of dental caries (63).
Also, bottle feeding with the juice during bedtime, frequent use of a sippy or no-spill cup,
and repeated consumption of between-meal snacks and beverages containing sugars
9

increase the risk of caries due to prolonged contact between sugars in the consumed food
or liquid and cariogenic bacteria on the teeth (64-66). According to the AAP
recommendations, infants should not be given juice from bottles or covered cups that allow
them to consume juice throughout the day, and intake of 100 percent fruit juice should be
limited to no more than four to six ounces per day for children one through six years old
(67).The caries conducive dietary practices such as frequent exposure to sugar, frequent
snacking, taking sweetened drinks to bed, sharing foods with adults, and dietary habits
appear to be established by 12 months of age and are maintained throughout early
childhood that predisposes to early microorganism colonization and establishment of caries
(60).
1.1.1.3.3 Environmental Factors
According to the AAPD, children should receive oral hygiene care upon the eruption of
the first primary tooth (68). Lack of good oral hygiene practices and lack of fluoride
exposure causes the development of ECC (63). The newly erupted teeth of immature
enamel and teeth with enamel hypoplasia are at higher risk of developing caries (69).
Studies have shown that the presence of enamel hypoplastic defects was associated with
prenatal conditions such as premature birth and low birth weight, as well as with
malnutrition and illness (70-72). Other factors such as caregivers’ social status, poverty,
ethnicity, deprivation, education, and dental insurance coverage have a significant
influence on the oral hygiene habits of children and the severity of ECC (22, 73, 74). It has
been shown that children from low socioeconomic parents are two times more likely to
have dental caries than from higher income parents (75).
10

1.1.1.4 Management of ECC
Maintaining a healthy primary dentition is important for the well-being of the child. The
primary dentition is essential for proper mastication, esthetics, phonetics, space
maintenance, and prevention of health issues resulting from primary teeth loss (77). ECC
preventive strategies start with prenatal education of expectant parent(s)/caregiver about
the etiology, feeding behaviors, and prevention of ECC, progress through the perinatal
period, and continue with the mother and infant (Figure 1.3) (2). Measures for adequate
dental treatment and maintenance good oral hygiene should be taken during pregnancy and
postnatal periods to reduce or delay ECC in infants (78-80). A recent study of the multilevel
conceptual model suggests that both social and behavioral change is important in the
prevention of ECC (81).
Prevention of dental caries in children can be achieved by performing dental plaque control
measures, changing the bacterial composition of plaque, diet counseling, maintain good
oral hygiene, and the use of preventive agents like fluorides (82). Fluorides are highly
effective in preventing dental caries including water fluoridation, fluoridated toothpaste,
fluoridated mouth rinse, and professional topical fluoride application, by antibacterial
effect, inhibiting demineralizing and promoting remineralization processes in the affected
tooth (83).
According to AAPD, the current best preventive practice to reduce the risk of ECC includes
twice-daily brushing with fluoridated toothpaste for all children in optimally-fluoridated
and fluoride-deficient communities by using a smear or rice-sized amount of fluoridated
toothpaste for children less than three years of age and a pea-sized amount of fluoridated
11

toothpaste for children aged three to six dispensed by parents onto a soft, age-appropriate
sized toothbrush who perform or assist with toothbrushing for preschool-aged children
(84).
Professionally applied topical fluoride treatments are also efficacious in reducing the
prevalence of ECC in children. According to the AAPD, children should receive oral
hygiene care upon the eruption of the first primary tooth (85). The recommended
professionally applied fluoride treatment for youngsters in danger of ECC who are younger
than six years is five percent sodium fluoride varnish (NaFV; 22,500 ppm F) (86). The
evidence on its effect in preventing dental caries has been reviewed in many narrative
reviews and systematic reviews/meta-analyses and showed that commercially available
formulation of sodium fluoride varnish of 5% is the most commonly used topical fluoride
agent in the management of ECC in the dental practice (86-88).

Figure 1.3: Strategies for the prevention of early childhood caries at various levels (2).
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1.1.2 SDF
Untreated decay in children remains clinical and public health challenge in the U.S. and
worldwide since it confers significant health and quality of life impacts children and their
parents (89, 90). Restorative work in young children and children with special health care
needs often requires advanced pharmacologic behavior guidance modalities (e.g., sedation,
general anesthesia) because of the lack in the ability to cope with the extensive treatment
procedures, that have additional health risks and limitations, such as possible effects on
brain development in young children (91), has mortality risks (92), often is not accessible,
at all or in a timely manner, and costly, especially when hospitalization is required (6, 93,
94).
Above noted downsides of traditional restorative treatment call for other alternative
modalities of caries management. SDF represents as an alternative modality for caries
treatment by arresting the rate of dental caries as much as 70 percent (i.e., higher than other
comparable interventions). Besides its efficacy, SDF has been favored based on its less
invasive (clinically and in terms of behavior guidance requirements) nature, and safety and
its inexpensiveness (92).
SDF has been used in Japan for over 40 years and, during the past decade, many other
countries such as Australia and China have been using it to arrest caries and reduce tooth
hypersensitivity in primary and permanent teeth (95). Recently, the Food and Drug
Administration (FDA) approved the dental application of SDF for reducing tooth
sensitivity, and off-label use of it for arresting caries (96, 97). As marketed in the United
States, SDF is a 38 percent silver diamine fluoride contain 24-28% silver and fluoride
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which is equivalent to five percent fluoride (44,800 ppm F) in a colorless liquid, with a pH
of 10 (98). The mechanism of SDF belongs to its composition containing silver and fluoride
that reduce S. mutans levels in oral biofilms (99), while inhibiting the process of
demineralization by conserving the collagen from degradation (100), and promoting dentin
remineralization by the interaction of fluoride ions with hydroxyapatite in an alkaline
environment to form fluorapatite which is less soluble than hydroxyapatite in an acidic
environment (101, 102)
Many clinical trials have evaluated the efficacy of SDF on caries arrest and/or prevention
and consistently concluded that SDF is more effective in arresting caries than fluoride
varnish (97, 101, 103-105). Upon administration to the tooth surface, SDF retains
approximately 2-3 times more fluoride than that delivered by sodium fluoride, stannous
fluoride, or acidulated phosphate fluoride (APF), those of which are commonly found in
foams, gels, and varnishes (106). It has been found that the annual application of SDF is
more effective in arresting caries lesions than the application of five percent sodium
fluoride varnish four times per year (107).
It is true that SDF also has some downsides. The major disadvantage of SDF is the dark
discoloration of carious dentin which is outweighed by its desirable properties in most
cases, especially when the use of advanced behavioral guidance techniques such as
sedation or general anesthesia to deliver traditional restorative care is avoided. According
to AAPD, SDF usage is indicated in a patient with high caries risk who have active
cavitated caries lesions in anterior or posterior teeth; in a patient who presents with
behavioral or medical management challenges and many cavitated caries lesions; in a
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patient with multiple cavitated caries lesions that may not all be treated in one visit; in a
patient with dental caries lesions that are difficult to treat; or in a patient without access to
or with difficulty accessing dental care (92). However, because of the esthetic concerns,
about one-third of parents found SDF treatment unacceptable under any circumstance
(108).
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1.2

CURRENT STUDY

1.2.1

Significance and Innovation

ECC is a signiﬁcant dental problem affecting preschool children worldwide. In general,
80% of the ECC is detected in preschool children from low-income family (44). Untreated
caries leads to the dental pulp and/or periapical infection, causing inflammation
accompanied by pain which may, in turn, affect a child’s growth, development and general
health (89, 90).
Results from several clinical studies revealed that, in addition to S. mutans infection, C.
albicans is frequently detected in high numbers in plaque-biofilms from children and
toddlers with ECC (44-48).
Traditionally, fluoride varnish is used to prevent ECC in children and adolescent (87, 88,
109). However, studies have shown that the SDF treatment had a good success rate in
inhibiting ECC progress in primary teeth (88, 92) and has advantage over fluoride varnish
in 1) extended in vivo half-life owing to Ammonia added in the solution 2) bactericidal
effects based on the presence of silver that possesses strong antimicrobial function (88,
101).
To the best of our knowledge, no research has ever addressed the inhibitory effect of SDF
on the growth of C. albicans, representing the scientific merit of this study. Despite the
drawback of SDF of black staining of caries affected teeth, such a cost-effective approach
is well-accepted to arrest caries in young and special care needs children. Especially, fewer
visits at dental office are needed for SDF-based treatment compared to the traditional
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restorative treatment. Therefore, the study of the possible effects of SDF on arresting C.
albicans-associated ECC may offer a translational significance and explore another
beneficial mechanism of SDF in arresting ECC to gain a better understanding of the
mechanism of SDF in arresting the C. albicans-associated ECC, in addition to its known
mechanisms.
1.2.2 Specific Aims
The ultimate goal of this study was to determine whether SDF has an inhibitory effect on
C. albicans. C. albicans is significantly associated with ECC and might be a risk factor in
ECC development (110).
Specific Objectives:
Specific Aim 1: To describe and compare the inhibitory effects of SDF, fluoride varnish,
fluconazole (positive control group), and PBS (negative control group) on two
concentrations of C. albicans (1 × 105/plate or 1 × 106/ plate).
Specific Aim 2: To determine the minimum inhibitory concentration (MIC) of SDF on the
growth of C. albicans of 1 × 105/plate.
1.2.3. Hypothesis
Hypothesis: There are significant differences in the inhibitory effect of SDF, fluoride
varnish, fluconazole (positive control group), and PBS (negative control group) on the
growth of C. albicans.
Null hypothesis: There are no significant differences in the inhibitory effect of SDF,
fluoride varnish, fluconazole (positive control group), and PBS (negative control group)
on the growth of C. albicans.
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CHAPTER 2: MATERIALS AND METHODS
2.1 Part1. Study Plan:
This study is an in vitro experimental study. It evaluated the antifungal effect of SDF (38%)
using both disk diffusion assay and minimum inhibitory concentration (MIC) assay which
are considered gold standards for testing.
In disk diffusion assay, the antifungal effect of SDF (38%) was evaluated and compared it
to that of fluoride varnish (5%), fluconazole (25 µg/mL, positive control group) and
Phosphate Buffered Saline (PBS: negative control group) on two different concentrations
of C. albicans (1 × 105/plate or 1 × 106/plate).
The experiment was performed in quadruplicates for each studied group (4 well/group) and
each experiment was repeated three times as recommended by many studies (111-114) and
according to Power analysis.
The number of observations were as follow, Figure 2.1: -For the concentration of C. albicans of 1 × 105/plate, the total number of the wells per
tested group was 12 and the total number of wells for all groups was 48.
-For the concentration of C. albicans of 1 × 106/plate, the total number of the wells per
tested group was 12 and the total number of wells for all groups was 48.
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Figure 2.1: Study plan of disk diffusion assay, G1=SDF (38%), G2=fluoride varnish (5%),
G3= fluconazole (25 µg/mL) (positive control group) and G4= Phosphate Buffered Saline
(PBS) (negative control group), G=Group.
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In MIC assay, the lowest concentration of SDF (38%) and fluconazole (25 µg/mL)
(positive control group) that inhibited the visible growth of C. albicans of 1 × 105 was
evaluated.
Twenty dilutions of each group were performed. For each dilution, 4 wells were used.
The number of observations were as follow, Figure 2.2: -For fluconazole (25 µg/mL): 20 dilutions, 4 well/dilution.
-For SDF (38%): 20 dilutions, 4 well/dilution.

Fluconazole (25 µg/mL)

SDF (38%)

Figure 2.2: Study plan of MIC assay, N=no treatment, D=dilution, B=blank.
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2.2 Part 2. Instrumentation:
1) Variables:
Independent variables:
The independent variables included SDF (38%) (Advantage arrest, USA. LOT # 19095),
Sodium fluoride varnish (5%) (FluroDose®, Centrex, USA, LOT # 360087),
fluconazole (25 µg/mL) (TCI, USA, LOT # EXZCF-KF), Phosphate Buffered Saline
(PBS), and C. albicans of 1 × 105/plate or 1 × 106/plate concentration (ATCC 10231)
(Fisher scientific, USA, LOT # 7003147).
Dependent variables:
In disk diffusion assay, the dependent variable was the diameter of the zone of growth
inhibition. More specifically, the diameters of the zone of inhibition (clear zone around
each well) obtained from four study arms, 1) SDF (38%), 2) fluoride varnish (5%), 3)
fluconazole (25 µg/mL) and 4) Phosphate Buffered Saline (PBS) on the C. albicans (1
× 105/plate or 1 × 106/plate) grown on the agar plates were measured in millimeter using
a digital caliper (Neiko, USA).
In MIC assay, the dependent variable was the lowest concentration of two test reagents,
1) SDF (serial dilutions of starting concentration of 38%), and 2) fluconazole (serial
dilutions of starting concentration of 25 µg/mL) that show at least 90% growth inhibition
of C. albicans incubated in culture broth.
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2) Reliability and Validity:
The inhibitory effects of SDF on growth of C albicans was evaluated using both disk
diffusion assay and MIC assay.
-MIC assay is the gold standard and the reference technique of antifungal susceptibility
test. Its method is standardized by various organizations, such as the Clinical and
Laboratory Standards Institute (CLSI), the International Organization for Standardization
(ISO) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST). It
is used to define the lowest concentration of an antimicrobial that will inhibit the visible
growth of a microorganism after overnight incubation (115). It is considered as a reliable
and standardized method for diagnostic purposes and used as a guide for the clinician to
the susceptibility of the organism to the antimicrobial agent and aids in treatment decisions
(116).
-Disk diffusion assay is one of the most commonly used antifungal susceptibility
comparison tests to evaluate the antifungal effects of reagents of interest. It is well accepted
to be simple, rapid, and cost-effective experiment, producing highly reproducible results
and correlate well with the MIC method, making agar-based method a viable alternative to
MIC assay for C. albicans susceptibility testing. The essential and strong agreements of
the results of disk diffusion assay to that of MIC assay for testing the susceptibility against
Candida is higher than 94%, rendering the disk diffusion assay as a valid screening
technique for testing the susceptibility of C. albicans strains (117-119).
-Intra and interexaminer reliability of the measurement of the diameter of the inhibition
zone using digital caliper is conducted after receiving a professional training from Dr.
Alireza Heidari. There was no significant difference in the values of the diameter of the
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inhibition zone in both intra and interexamination.
2.3 Part 3. Design and Procedure:
1) Research design: This research is an in vitro experimental-complete randomized blockdesign.
2) Study Groups and Procedures:
In disk diffusion assay, there were four tested groups as shown in Table 2.1.
Table 2.1: The tested groups and their roles:
Group 1

SDF (38%)

Experimental group

Group 2

fluoride varnish (5%)

Experimental group

Group 3

fluconazole (25 µg/mL)

Positive control group

Group 4

PBS

Negative control group

The experiment was conducted in a laminar flow hood (Air Science® FLOW-36 Purair®
FLOW) and the prepared agar plates were incubated at 36 ± 1⁰C in the aerobic condition
in an incubator (VWR, USA) according to the methods for antifungal disk diffusion
susceptibility testing guideline (120), and as shown in Figure 2.3.
a) Preparation of the suspensions of C. albicans: C. albicans cultured in Sabouraud
Dextrose Broth (SDB, Difco Laboratories) at mid log growth phase (OD600 = 0.81.0) was harvested, and suspended in 2 mL of sterile Phosphate Buffered Saline
(PBS) to yield an inoculum (1 × 105 or 1 × 106 colony-forming units (CFU)/50
μL) based on optical density (OD) at 600 nm (conversion factor: 1 U at OD600 is
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equal to approximately 3 × 107 CFU/mL). OD600 was measured using a plate
reader (Synergy H1, BioTek).

b) Preparation of growth plate: Fifty µL of suspension containing 105 or 106
CFU/mL of C. albicans was plated onto Mueller-Hinton agar Mueller Hinton Agar
(Prepared Media Plates 150 x 15 mm, Corolina, USA), evenly spread with the
bacterial cell spreader (VWR, USA) over the entire agar surface. This procedure
was repeated by streaking two more times, rotating the plate approximately 60°
each time to ensure an even distribution of inoculum.
c) Preparation of the tested materials: As a positive control antifungal agent,
fluconazole (TCI, USA) was employed. Distilled water was used as a solvent for
fluconazole. The stock solution of 1280 𝜇g/mL was prepared. Then, the final
concentration of 25 𝜇g/mL was prepared using the equation of:
C1V1=C2V2 ……………………………………………………(1)
C1 = Initial concentration of solution
V1 = Initial volume of solution
C2 = Final concentration of solution
V2 = Final volume of solution
The surface of Mueller-Hinton agar in a plastic Petri dish was divided into 4 equal
quadrants. In each quadrant, a paper disk filter (Whatman® Antibiotic Assay Discs, 6
mm Ø, Sigma Aldrich) was placed at equal distance. Then, 20 µL of the test solutions
containing respective test reagent was applied to a paper disk separately.

24

d) Incubation: Plates were incubated at 36 ± 1⁰C for 24 hrs in the aerobic condition
in an incubator. After 24 hrs of incubation, the zone of inhibition was measured.
e) Measuring the diameter of the zone of inhibition: The diameter of the zone of
inhibition (clear zone around each well) was measured with a digital caliper in
millimeters. Petri dishes were also photographed to keep the records of results.

Figure 2.3: The steps of method for antifungal disk diffusion assay.
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In MIC assay, serially diluted SDF and fluconazole (positive control group) were reacted
to suspension of C. albicans at the concentration below the detectable range by a plate
reader.
To avoid the contamination of airborne bacteria, the preparation of MIC assay was
conducted in a laminar flow hood according to the method of MIC testing guideline (121)
and as shown in Figure 2.4.
Twenty serial dilutions of SDF (starting conc. at 38%) and fluconazole (starting conc. at
25 µg/mL) in distilled water were prepared in a 96-well plate (VWR, USA). For each
dilution, 4 wells were used (quadruplicate). Then, 10 µL of serially diluted SDF or
fluconazole was applied to C. albicans (1×105 cells/mL) suspended in Sabouraud Dextrose
broth (90 µL/well).
The plate was incubated at 36 ± 1⁰C for 24 hrs in the aerobic condition. After 24 hrs of
incubation, the growth of C. albicans was measured using a plate reader.

Figure 2.4: The steps of method for MIC testing.
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2.4 Part 4. Power Analysis
A power analysis was performed using the guidelines provided in Sample Size Choice by
Odeh, R.E. and Fox, M. (122) and Pass 16 software (NCSS, LLC) functionality. Table 2.2
shows the power analysis for a Randomized Block Analysis of Variance displaying the
stipulated conditions.

Table 2.2: Randomized Block Analysis of Variance
Numeric Results

Term

A

Number
of
Power Blocks Units df1
Alpha
Beta

0.6604
0.05

4
0.34

12

df2

2

6

Standard
BlockDeviation Treatment
of Means Interaction
(σm)
(σ)

1.000

Definitions of terms used:
Power is the probability of rejecting a false null hypothesis.
Blocks are the number of plated in the design.
Units are the number of experimental units in the design.
df1 is the numerator degrees of freedom.
df2 is the denominator degrees of freedom.
σm is the standard deviation of the group means or effects.
σ is the pooled block-treatment interaction.
Effect Size is the ratio σm/σ
Alpha is the probability of rejecting a true null hypothesis.
Beta is the probability of accepting a false null hypothesis.
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1.000

Effect
Size
(σm/σ)

1.000

A randomized-block design with one treatment factor at 4 levels has 4.0 blocks each with
4.0 treatment combinations. The square root of the block-treatment interaction is 1.000.
This design achieves 77% power when an F test is used to test factor A at a 5% significance
level and the actual standard deviation among the appropriate means is 1.000 (an effect
size of 1.000).
2.5 Part 5. Statistical Analysis
For the analysis of results from disk diffusion assay: Univariate statistics was calculated
for all study variables. Results were expressed as a mean ± SD. Statistical analysis was
done using a statistical package, R 3.4.2. The susceptibility of the studied groups (control
groups and experimental groups) was compared using Randomized Block Analysis of
Variance test followed by the Tukey’s HSD test for multiple comparisons. An alpha of.05
was employed to test the null hypothesis.
For the analysis of MIC assay: Results were expressed as a mean ± SD. The minimum
inhibitory concentration results were expressed as a percentage (wt/vol %) of respective
test reagent.
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CHAPTER 3: RESULTS
3.1 Disk Diffusion Assay
The diameter of inhibition zone (clear zone around each well) of SDF (38%), fluoride
varnish (5%), fluconazole (25 µg/mL), PBS on C. albicans of 1 × 105/plate or 1 × 106/plate
concentration was measured in millimeter with a digital caliper. The concentrations of SDF
and fluoride varnish were employed from those used in dental practice.
For C. albicans of 1 × 105/plate, the diameter of inhibition zone of SDF and fluconazole
(positive control group) was 26.60 ± 0.64 mm and 17.25 ± 1.50 mm, respectively. No
visible inhibition zone for fluoride varnish or PBS (negative control group) was detected,
as shown in Figure 3.1, and Table 3.1.
A one-way ANOVA was conducted to see if the diameter of inhibition zone is statistically
different among SDF, fluoride varnish, fluconazole (positive control group), and PBS
(negative control group). The results showed that there is a statistically significant
difference in the diameter of inhibition among SDF, fluconazole, fluoride varnish and PBS
on the C. albicans grown at the concentration of 1 × 105/plate, F(3,44) = 3089.64, p < .001,
as shown in Table 3.2.
Tukey test was conducted to detect the significant difference between each two groups.
The results showed that there was a statistically significant between 1) SDF and
fluconazole, 2) SDF and fluoride varnish or PBS, 3) fluconazole and fluoride varnish or
PBS, p < .001. There was no significant difference between fluoride varnish and PBS
groups p = 1.00, as shown in Figure 3.2, and Table 3.3.
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Figure 3.1: The inhibition zone of SDF, fluoride varnish, fluconazole (positive control
group), and PBS (negative control group) for C. albicans concentration of 1 × 105/plate.
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Table 3.1: The diameter of inhibition zone (mm) of SDF, fluoride varnish, fluconazole
(positive control group), and PBS (negative control group) for C. albicans concentration
of 1 × 105/plate.

Groups

Diameter of inhibition zone (mm)
for C. albicans conc. of 1 × 105/plate
N

Average

SD

Min

Max

SDF (38%)

12

26.60

0.64

25.43

27.62

Fluoride varnish (5%)

12

0.10

0.00

0.10

0.10

Fluconazole (25 µg/mL)

12

17.25

1.50

15.77

18.74

PBS

12

0.10

0.00

0.10

0.10

Table 3.2: One-Way ANOVA of the diameter of inhibition zone (mm) of SDF, fluoride
varnish, fluconazole (positive control group), and PBS (negative control group) for C.
albicans concentration of 1 × 105/plate, * means significant difference.
Source

DF

Sum of Squares

Mean Square F Ratio

P-value

Group

3

6242.06

2098.68

0.000*

Error

44

29.63

0.67

Total

47

6271.69
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3089.64

Table 3.3: Tukey test of the difference of the diameter of inhibition zone (mm) of SDF,
fluoride varnish, fluconazole (positive control group), and PBS (negative control group)
for C. albicans concentration of 1 × 105/plate, * means significant difference.

Groups

Difference

Lower 95% CI

Upper 95% CI

p-Value

1 vs 2

26.50417

25.6097

27.39868

0.000*

1 vs 4

26.50417

25.7097

27.49868

0.000*

3 vs 2

17.15000

16.2555

18.04451

0.000*

3 vs 4

17.15000

16.2555

18.04451

0.000*

1 vs 3

9.35417

8.4597

10.24868

0.000*

4 vs 2

0.00000

-0.8945

0.89451

1.000
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Fluconazole
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Figure 3.2: Comparisons of the difference of the inhibition zone (mm) of SDF to that of
fluoride varnish, fluconazole (positive control group), and PBS (negative control group)
for C. albicans concentration of 1 × 105/plate,
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= Significant difference.

For C. albicans applied at the concentration of 1 × 106/plate, the diameter of the inhibition
zone of SDF and fluconazole (positive control group) was 25.68 ± 1.06 mm and 16.05 ±
1.61 mm, respectively. No visible inhibition zone for fluoride varnish or PBS (negative
control group) was detected, as shown in Figure 3.3, and Table 3.4.
A one-way ANOVA was conducted to see if the diameter of inhibition zone is statistically
different among SDF, fluoride varnish, fluconazole (positive control group), and PBS
(negative control group). The results showed that there is a statistically significant
difference in the diameter of inhibition zone among SDF, fluconazole, fluoride varnish and
PBS on the C. albicans grown at concentration of 1 × 106/plate, F(3,44) = 2035.37, p <
.001, as shown in Table 3.5.
Tukey test was conducted to detect the significant difference between each two groups, the
results showed that there was a statistically significant difference between 1) SDF and
fluconazole, 2) SDF and fluoride varnish or PBS, 3) fluconazole and fluoride varnish or
PBS, p < .001. There was no significant difference between fluoride varnish and PBS
groups p = 1.00, as shown in Figure 3.4, and Table 3.6.

34

Figure 3.3: The inhibition zone of SDF, fluoride varnish, fluconazole (positive control
group), and PBS (negative control group) on C. albicans concentration of 1 × 106/plate.
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Table 3.4: The diameter of inhibition zone (mm) of SDF, fluoride varnish, fluconazole
(positive control group), and PBS (negative control group) for C. albicans concentration
of 1 × 106/plate.

Groups

Diameter of inhibition zone (mm)
for C. albicans conc. of 1 × 106/plate
N

Average

SD

Min

Max

SDF (38%)

12

25.68

1.06

23.66

27.20

Fluoride varnish (5%)

12

0.10

0.00

0.10

0.10

Fluconazole (25 µg/mL)

12

16.05

1.61

13.14

18.82

PBS

12

0.10

0.00

0.10

0.10

Table 3.5: One-Way ANOVA of the diameter of inhibition zone (mm) of SDF, fluoride
varnish, fluconazole (positive control group), and PBS (negative control group) for C.
albicans concentration of 1 × 106/plate, * means significant difference.
Source

DF

Sum of Squares

Mean

F Ratio

P-value

2035.37

0.000*

Square
Groups

3

5733.88

1911.29

Error

44

41.31

0.94

Total

47

5775.20
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Table 3.6: Tukey test of the difference of diameter of inhibition zone (mm) of SDF,
fluoride varnish, fluconazole (positive group), and PBS (negative group) for C. albicans
concentration of 1 × 106/plate, * means significant difference.
Groups

Difference

Lower 95% CI

Upper 95% CI

p-Value

1 vs 2

25.58583

24.5296

26.64211

0.000*

1 vs 4

25.58583

24.5296

26.64211

0.000*

3 vs 2

15.95833

14.9021

17.01461

0.000*

3 vs 4

15.95833

14.9021

17.01461

0.000*

1 vs 3

9.62750

8.5712

10.68378

0.000*

4 vs 2

0.00000

-1.0563

1.05628

1.000
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Figure 3.4: Comparing the difference of the diameter of inhibition zone (mm) of SDF to
that of fluoride varnish, fluconazole (positive control group), and PBS (negative control
group) for C. albicans concentration of 1 × 106/plate,
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= Significant difference.

A t-test was conducted to see if the diameter of inhibition zone of SDF is different on C.
albicans concentrations of 1 × 105/plate and 1 × 106/plate, the result showed that there is
no significant difference between the diameter of inhibition zone of SDF on both C.
albicans concentrations of 1 × 105/plate and 1 × 106/plate, t( 18.11) = 2.105, p = .161,
despite the diameter of inhibition zone by SDF on C. albicans of 1 × 105/plate (Mean =
26.60, SD = 0.64) was more than that on C. albicans of 1 × 106/plate (Mean = 25.68, SD =
1.06), as shown in Figure 3.5.

27.5
27
26.5
26
25.5
25
24.5
24
C. albicans conc. of 1 × 105/plate

C. albicans conc. of 1 × 106/plate

Figure 3.5: Comparing the diameter of inhibition zone of SDF on C. albicans of 1 ×
105/plate and 1 × 106/plate.
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3.2 MIC Assay
In MIC assay, the antifungal effect of the serial dilutions of SDF (starting conc. 38%) and
fluconazole (starting conc. 25 µg/mL) was compared. The MIC of SDF was 0.009% of its
original concentration, while the MIC of fluconazole was 0.6% of its original concentration
as shown in Figure 3.6.

SDF MIC
1.2

OD (600 nm)

1
0.8
0.6
0.4
0.2
0
0 treatment

0.25

0.08

0.02

0.009

0.003

0.001

Concentration %

Fluconozole MIC
1.2

OD (600 nm)

1
0.8
0.6
0.4
0.2
0
0
treatment

2

0.6

0.2

0.07

0.025

0.008

0.002

Concentration %
Figure 3.6: MIC of SDF (38%) and fluconazole (25 µg/mL): MIC is indicated by the
star.
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3.3 SUMMARY of FINDINGS:

1) There is a statistically significant difference in the diameter of inhibition zone between
1) SDF and fluconazole, 2) SDF and fluoride varnish or PBS, 3) fluconazole and fluoride
varnish or PBS on the C. albicans grown at the concentration of 1 × 105/plate.

2) There is a statistically significant difference in the diameter of inhibition zone between
1) SDF and fluconazole, 2) SDF and fluoride varnish or PBS, 3) fluconazole and fluoride
varnish or PBS on the C. albicans grown at the concentration of 1 × 106/plate.

3) There is no significant difference between the diameter of inhibition zone of SDF on
both C. albicans concentrations of 1 × 105/plate and 1 × 106/plate.

4) The MIC of SDF was 0.009% of its original concentration, while the MIC of fluconazole
was 0.6% of its original concentration.
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CHAPTER 4: DISCUSSION
The treatment of ECC is often expensive, requiring extensive restorative procedure and/or
extraction of teeth at an early age with a demand of sedation or general anesthesia at times
due to the lack of the ability to cope with the extensive treatment procedures in young
children (82). SDF is considered as a cost-effective therapeutic agent for dental caries
reduction in preschool children and in children with special care needs. It has a good
success rate in preventing the progress of ECC by inhibiting the process of
demineralization, conserving the collagen from degradation, enhancing dentin
remineralization, and reducing S. mutans levels in oral biofilms (94).
S. mutans is considered as the major pathogen in ECC. However, C. albicans has been
implicated as one of the major contributing factors for the high prevalence of ECC.
Therefore, the purpose of this study was to evaluate the possible inhibitory effect of SDF
on the growth of C. albicans that would further explain the success of SDF in arresting
ECC.
4.1 Disk Diffusion Assay
The results using disk diffusion method showed that SDF had a significant inhibitory effect
on the growth of C. albicans, even more than fluconazole (positive control group), and 5%
fluoride varnish. Fluoride varnish did not exhibit any inhibitory effect on the growth of C.
albicans.
SDF contains approximately 24-28 percent (weight/volume) silver and 5-6 percent fluoride
(weight/volume) (92). The ability of SDF to suppress the growth of C. albicans can be
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attributed to the silver content of SDF. Silver compounds have a long history of use in both
medicine and dentistry because of their antimicrobial properties. It has been reported that
silver particles suppressed the growth of various pathogenic fungi such as Candida,
Aspergillus, and Cryptococcus species (123, 124), and even the antifungal drug-resistant
C. albicans was inhibited by silver particles (125).
Treating C. albicans with silver for 24 hours lead to suppress C. albicans biofilm formation
and disrupt the structural layers of the outer fungal cell wall (126, 127).
It has been concluded that the multitargeted action of silver including generation of
intracellular reactive oxygen species (ROS), alterations in ergosterol content, and
membrane fluidity together seem to have potentiated anti-Candida action (128). Also, the
combination of silver with 3-bromopyruvate enhanced cell death in C. albicans (129).
Furthermore, it was revealed that silver affected multiple process vital for pathogenesis of
C. albicans and pivotal for its virulence and biofilm formation including alteration of
surface morphology, cellular ultrastructure, membrane microenvironment, membrane
fluidity, ergosterol content, and fatty acid composition, especially oleic acid (130).
On the other hand, it was reported that the fungicidal capacity of silver, after the exposure
time of 24 h, came from the aggregation of silver particles outside the fungal cells, releasing
silver ions and inducing cell death through the reduction process resulting from the
interaction of cell wall and cytoplasm with ionic silver (131).
Kim et al., showed that the activity of silver against C. albicans was found to be
comparable to that of amphotericin B, but superior to that of fluconazole (126), which
explain our study’s results that showed the inhibitory effect of SDF against C. albicans
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growth is more than that of fluconazole since SDF contains silver in its composition. To
our knowledge, no study done before to investigate the inhibitory effect of SDF on the
growth of C. albicans to compare our results to it.
Also, the result of the comparison between the diameter of inhibition zone of SDF on both
C. albicans concentrations of 1 × 105/plate and 1 × 106/plate showed no significant
difference between them. That means even when the concentration of C. albicans elevated
by 10 times, SDF still exhibited an inhibitory effect on the growth of C. albicans and there
was no significant difference in the diameter of inhibition zone of SDF on both
concentrations of C. albicans.
In this study’s results, 5% sodium fluoride varnish did not exhibit any antifungal effect on
the growth of C. albicans. This result is consistent with the result of a study done to
compare the antifungal effect of commonly used fluorides which were 5% fluoride varnish,
and amine fluoride/stannous fluoride combination (AmF/SnF2) comparing their antifungal
effect to that of chlorhexidine (positive control group) using MIC. It has been found that
the inhibitory effect on the growth of C. albicans of AmF / SnF2 was comparable with that
of chlorhexidine, whereas 5% fluoride varnish had the weakest effect (132).
Also, other study comparing the inhibitory effect of several commercial mouthwashes with
various, active ingredients of fluoride (FLO), cethylpyridinium chloride (CPC),
chlorhexidine gluconate (CHX), triclosan (TRI) and herbal extracts: Twin Lotus (TLO)
and Herbric concentrated (HBC) on C. albicans activities included growth, germ tube
formation and adhesion to human buccal mucosa. It was reported that TRI, TLO and CHX
mouthwashes had growth inhibitory effects to C. albicans. CHX, TRI, TLO, HBC and CPC
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mouthwashes had ability to inhibit adhesion of C. albicans. CHX, TRI and CPC
mouthwashes had ability to suppress germ tube formation, and mycelial conversion of C.
albicans. However, fluoride mouthwash showed the weakest in all inhibitory activities
(133).
It can be concluded that the antifungal effect of SDF belongs to its silver content since the
fluoride component in fluoride varnish did not show any inhibitory effect on the growth of
C. albicans. In clinical studies, it has been illustrated that SDF is more efficient than
fluoride varnish in arresting ECC because of its composition of high concentration of silver
and fluoride. It was reported that SDF was more effective in arresting dentin caries in
primary anterior teeth in pre-school children than 5% fluoride varnish (104, 106, 134).
Also, it has been found that annual application of SDF was more effective in arresting
caries lesions than application of five percent sodium fluoride varnish four times per year
(107).
4.2 MIC Assay
In this study, MIC assay was used to determine the minimum SDF concentration that can
inhibit the growth of C. albicans. MIC assay is considered as the gold standard and a
reference technique of antifungal susceptibility test that used to define the lowest
concentration of an antimicrobial that will inhibit the visible growth of a microorganism
after overnight incubation (115). The result showed that the MIC of SDF was 0.009% of
its original concentration, which means SDF can inhibit the growth of C. albicans at lower
concentration than antifungal effect mediated by fluconazole, making the effect of saliva
dilution to minimum after clinical application. For our knowledge, no study of SDF’s MIC
conducted before to compare our result to it.
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CHAPTER 5: CONCLUSIONS
This study, for the first time, demonstrated the inhibitory effect of SDF on the growth of
C. albicans, indicating that SDF possesses sufficiently efficient antifungal property as
determined by the significantly lesser MIC of SDF to suppress the growth of C. albicans
compared to fluconazole. This study gained a mechanistic insight into the microbiological
impact of SDF in arresting the C. albicans-associated ECC and discovered a new beneficial
antifungal efficacy of SDF, in addition to its known mechanisms in preventing the growth
of S. mutans and inhibition of dentin demineralization. This finding is expected to lead to
a development of novel approach in arresting ECC associated with C. albicans.

46

Recommendations for future studies
•

To study the effect of SDF in vivo using animal models.

•

To study the inhibitory effect of SDF on a combination of C. albicans and S. mutans.

•

To include other compositions of fluoride such as acidulated phosphate fluoride, and
stannous fluoride.

Publication plan
The results of this study have been presented in REACH Day at Nova Southeastern
University in February 21, 2020 and was judged as Outstanding by the Research
Committee. Also, it has been presented in AAPD annual meeting at Nashville, TN in May
22-24, 2020 and will be sent for publication to Journal of Dental Research.
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